Mark A. Powelson
Amministratore Delegato presso XCR Diagnostics, Inc.
Profilo
Mark A.
Powelson is currently the President, Chief Executive Officer & Director at XCR Diagnostics, Inc. He is also the Chief Operating Officer at XCR Dx.
Previously, he held positions as Vice President-Worldwide Sales at Gen-Probe, Inc., Vice President-Sales & Marketing at HandyLab, Inc., and Principal at Point of Care Technologies, Inc. Mr. Powelson completed his undergraduate degree at Otterbein College and his graduate degree at the University of San Diego.
Posizioni attive di Mark A. Powelson
| Società | Posizione | Inizio |
|---|---|---|
| XCR Dx | Direttore operativo | - |
XCR Diagnostics, Inc.
 XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Amministratore Delegato | 01/04/2016 |
Precedenti posizioni note di Mark A. Powelson
| Società | Posizione | Fine |
|---|---|---|
HandyLab, Inc.
 HandyLab, Inc. Medical SpecialtiesHealth Technology HandyLab, Inc. develops and manufactures novel clinical diagnostic testing products. It serves medical, industrial and bio-defense markets. The company was founded by Kalyan Handique and Sundaresh Brahmasandra in 2000 and is headquartered in Plymouth, MI. | Vendite & Marketing | - |
| Point of Care Technologies, Inc. | Corporate Officer/Principal | - |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Vendite & Marketing | - |
Formazione di Mark A. Powelson
| Otterbein College | Undergraduate Degree |
| University of San Diego | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
HandyLab, Inc.
HandyLab, Inc. Medical SpecialtiesHealth Technology HandyLab, Inc. develops and manufactures novel clinical diagnostic testing products. It serves medical, industrial and bio-defense markets. The company was founded by Kalyan Handique and Sundaresh Brahmasandra in 2000 and is headquartered in Plymouth, MI. | Health Technology |
| Point of Care Technologies, Inc. | Health Technology |
| XCR Dx | |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Mark A. Powelson
